A patient with HFrEF remains symptomatic in sinus rhythm at 82 beats/min despite maximally tolerated beta-blocker, ACE inhibitor, MRA and SGLT2

Question

A patient with HFrEF remains symptomatic in sinus rhythm at 82 beats/min despite maximally tolerated beta-blocker, ACE inhibitor, MRA and SGLT2 inhibitor. LVEF is 30%. Which specialist option fits NICE criteria?

Accepted Answer

Ivabradine with heart-rate and rhythm follow-up

Answer

Digoxin, solely to provide an additional mortality benefit

Answer

Diltiazem, with blood-pressure and ventricular-function follow-up

Answer

Verapamil, with PR-interval and ventricular-function follow-up

Answer

Flecainide, with QRS-duration and renal-function follow-up

HF with reduced ejection fraction — GPhC CRA MCQ

A patient with HFrEF remains symptomatic in sinus rhythm at 82 beats/min despite maximally tolerated beta-blocker, ACE inhibitor, MRA and SGLT2 inhibitor. LVEF is 30%. Which specialist option fits NICE criteria?